+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Paediatric Healthcare Market by Treatment, Indication, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 4968855
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Paediatric Healthcare Market grew from USD 107.01 billion in 2023 to USD 114.55 billion in 2024. It is expected to continue growing at a CAGR of 7.53%, reaching USD 177.94 billion by 2030.

The scope of the pediatric healthcare market encompasses a vast array of services and products dedicated to the care of children from infancy through adolescence. The necessity for pediatric healthcare arises from the unique medical needs of children, whose growth and developmental stages require specialized treatment and preventive care. Applications include a wide range of medical specialties such as neonatology, pediatric oncology, cardiology, and developmental pediatrics, among others. The end-use scope spans hospitals, clinics, research institutions, and home healthcare settings. Market growth is significantly influenced by factors such as technological advancements in diagnostic and treatment equipment, rising prevalence of pediatric diseases, increased healthcare expenditure, and heightened awareness about child health and wellness. Emerging opportunities are evident in telemedicine services, personalized medicine, and AI-driven predictive healthcare solutions, particularly as parents seek more convenient and effective healthcare options for their children. Companies can capitalize on these opportunities by investing in technologies that enhance patient engagement and healthcare delivery efficiency.

However, challenges include regulatory complexities, high research and development costs, and disparities in healthcare accessibility across various regions. These limitations can impede market expansion, especially in developing nations where infrastructure may not support advanced pediatric care. The best areas for innovation and research comprise the development of non-invasive diagnostic tools, mobile health applications tailored for pediatric care, and the advancement of genetic research to better understand pediatric diseases. The market is characterized by a competitive landscape where collaboration among healthcare providers, technological firms, and policy-makers could better tackle existing challenges. To thrive, businesses should focus on strategic partnerships and leverage real-time data for predictive analytics in early disease detection and management. Overall, the pediatric healthcare market is poised for growth with significant room for innovation, but it requires careful navigation of regulatory hurdles and cost management to fully harness its potential.

Understanding Market Dynamics in the Paediatric Healthcare Market

The Paediatric Healthcare Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing number of deaths attributed to viral infections and malnutrition
    • Rising government support and initiatives to promote pediatric health
    • Growing awareness among child parents for adequate treatment
  • Market Restraints
    • Ethical concerns and small size of the study population
  • Market Opportunities
    • Growing research and development in technological advancements
    • Surge in medical expenditure in emerging economies
  • Market Challenges
    • Lack of pediatricians across the globe

Exploring Porter’s Five Forces for the Paediatric Healthcare Market

Porter’s Five Forces framework further strengthens the insights of the Paediatric Healthcare Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Paediatric Healthcare Market

External macro-environmental factors deeply influence the performance of the Paediatric Healthcare Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Paediatric Healthcare Market

The Paediatric Healthcare Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Paediatric Healthcare Market

The Paediatric Healthcare Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Paediatric Healthcare Market

The Paediatric Healthcare Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Paediatric Healthcare Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AstraZeneca PLC, Aveanna Healthcare, LLC., Becton, Dickinson and Company, bioMérieux SA, Boehringer Ingelheim International GmbH, Eisai Co., Ltd., Eli Lilly and Company, Enviva Inc., Gilead Sciences, Inc., Glaxosmithkline PLC, GP Pharm, S.A., Henin Lukinz Pvt. Ltd., Interim HealthCare Inc., Janssen Global Services LLC, Johnson & Johnson Services, Inc., Medexus Pharmaceuticals, Inc., Medtronic PLC, Merck KGaA, Novartis AG, Olympus Corporation, ORPHELIA Pharma, Pfizer Inc., Proveca Ltd., Royal Philips, Sanofi S.A, Siemens AG, Strykar Corporation, The Procter & Gamble Company, Thermo Fisher Scientific, Inc., and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Paediatric Healthcare Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Treatment
    • Immunotherapy
    • Medications
    • Surgeries
  • Indication
    • Asthma & Allergies
    • Cardiac Disorders
    • Genetic Disorders
    • Metabolic Disorders
  • End-User
    • Ambulatory Care Centers
    • Homecare Settings
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing number of deaths attributed to viral infections and malnutrition
5.1.1.2. Rising government support and initiatives to promote pediatric health
5.1.1.3. Growing awareness among child parents for adequate treatment
5.1.2. Restraints
5.1.2.1. Ethical concerns and small size of the study population
5.1.3. Opportunities
5.1.3.1. Growing research and development in technological advancements
5.1.3.2. Surge in medical expenditure in emerging economies
5.1.4. Challenges
5.1.4.1. Lack of pediatricians across the globe
5.2. Market Segmentation Analysis
5.2.1. Treatment: Expanding usage of pediatric healthcare for immunotherapy for a myriad of health conditions
5.2.2. Indication: Growing need for effective, age-appropriate medications in pediatric healthcare to manage asthma & allergies
5.2.3. End-User: Growing usage of pediatric healthcare across hospitals & clinics that offer a wide range of services
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Paediatric Healthcare Market, by Treatment
6.1. Introduction
6.2. Immunotherapy
6.3. Medications
6.4. Surgeries
7. Paediatric Healthcare Market, by Indication
7.1. Introduction
7.2. Asthma & Allergies
7.3. Cardiac Disorders
7.4. Genetic Disorders
7.5. Metabolic Disorders
8. Paediatric Healthcare Market, by End-User
8.1. Introduction
8.2. Ambulatory Care Centers
8.3. Homecare Settings
8.4. Hospitals & Clinics
9. Americas Paediatric Healthcare Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Paediatric Healthcare Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Paediatric Healthcare Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Cortica Closes USD 75 Million in New Funding Round and Acquires Springtide Child Development
12.3.2. Pediatric Behavioral Health Provider Bend Health Moves Out of Stealth Mode with USD 32M in Funding
12.3.3. Ipsen to Acquire Albireo Accelerating Growth in Rare Disease with Treatments for Several Pediatric Liver Diseases
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. PAEDIATRIC HEALTHCARE MARKET RESEARCH PROCESS
FIGURE 2. PAEDIATRIC HEALTHCARE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. PAEDIATRIC HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. PAEDIATRIC HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. PAEDIATRIC HEALTHCARE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. PAEDIATRIC HEALTHCARE MARKET DYNAMICS
TABLE 7. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY SURGERIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY ASTHMA & ALLERGIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY CARDIAC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 31. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 32. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 34. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 35. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. CHINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 48. CHINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 49. CHINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. INDIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 51. INDIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 52. INDIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. JAPAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 57. JAPAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 58. JAPAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. THAILAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 75. THAILAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 76. THAILAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 84. DENMARK PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 85. DENMARK PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 86. DENMARK PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. EGYPT PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 88. EGYPT PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 89. EGYPT PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. FINLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 91. FINLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 92. FINLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. FRANCE PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 94. FRANCE PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 95. FRANCE PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. GERMANY PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 97. GERMANY PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 98. GERMANY PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. ITALY PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 103. ITALY PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 104. ITALY PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. NORWAY PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 112. NORWAY PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 113. NORWAY PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. POLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 115. POLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 116. POLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. QATAR PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 118. QATAR PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 119. QATAR PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. SPAIN PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 130. SPAIN PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 131. SPAIN PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. TURKEY PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 139. TURKEY PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 140. TURKEY PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. PAEDIATRIC HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 148. PAEDIATRIC HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Paediatric Healthcare market, which are profiled in this report, include:
  • Abbott Laboratories
  • AstraZeneca PLC
  • Aveanna Healthcare, LLC.
  • Becton, Dickinson and Company
  • bioMérieux SA
  • Boehringer Ingelheim International GmbH
  • Eisai Co., Ltd.
  • Eli Lilly and Company
  • Enviva Inc.
  • Gilead Sciences, Inc.
  • Glaxosmithkline PLC
  • GP Pharm, S.A.
  • Henin Lukinz Pvt. Ltd.
  • Interim HealthCare Inc.
  • Janssen Global Services LLC
  • Johnson & Johnson Services, Inc.
  • Medexus Pharmaceuticals, Inc.
  • Medtronic PLC
  • Merck KGaA
  • Novartis AG
  • Olympus Corporation
  • ORPHELIA Pharma
  • Pfizer Inc.
  • Proveca Ltd.
  • Royal Philips
  • Sanofi S.A
  • Siemens AG
  • Strykar Corporation
  • The Procter & Gamble Company
  • Thermo Fisher Scientific, Inc.
  • Viatris Inc.

Methodology

Loading
LOADING...

Table Information